Works matching IS 19466234 AND DT 2023 AND VI 15 AND IP 723

Results: 7

Translating models of obesity to tackle common obesity.
Published in:
Science Translational Medicine, 2023, v. 15, n. 723, p. 1, doi. 10.1126/scitranslmed.adh5425
By:
- Ulijaszek, Stanley
Publication type:
Article
Seeking satiety: From signals to solutions.
Published in:
Science Translational Medicine, 2023, v. 15, n. 723, p. 1, doi. 10.1126/scitranslmed.adh4453
By:
- Tschöp, Matthias H.;
- Friedman, Jeffrey M.
Publication type:
Article
Obesity and lifespan, a complex tango.
Published in:
Science Translational Medicine, 2023, v. 15, n. 723, p. 1, doi. 10.1126/scitranslmed.adh1175
By:
- Diaz-Ruiz, Alberto;
- Price, Nathan L.;
- Ferrucci, Luigi;
- de Cabo, Rafael
Publication type:
Article
Evidence for the contribution of the gut microbiome to obesity and its reversal.
Published in:
Science Translational Medicine, 2023, v. 15, n. 723, p. 1, doi. 10.1126/scitranslmed.adg2773
By:
- de Wit, Douwe F.;
- Hanssen, Nordin M. J.;
- Wortelboer, Koen;
- Herrema, Hilde;
- Rampanelli, Elena;
- Nieuwdorp, Max
Publication type:
Article
Metaflammation in obesity and its therapeutic targeting.
Published in:
Science Translational Medicine, 2023, v. 15, n. 723, p. 1, doi. 10.1126/scitranslmed.adf9382
By:
- Schleh, Michael W.;
- Caslin, Heather L.;
- Garcia, Jamie N.;
- Mashayekhi, Mona;
- Srivastava, Gitanjali;
- Bradley, Anna B.;
- Hasty, Alyssa H.
Publication type:
Article
Hyperleptinemia contributes to antipsychotic drug–associated obesity and metabolic disorders.
Published in:
Science Translational Medicine, 2023, v. 15, n. 723, p. 1, doi. 10.1126/scitranslmed.ade8460
By:
- Zhao, Shangang;
- Lin, Qian;
- Xiong, Wei;
- Li, Li;
- Straub, Leon;
- Zhang, Dinghong;
- Zapata, Rizaldy;
- Zhu, Qingzhang;
- Sun, Xue-Nan;
- Zhang, Zhuzhen;
- Funcke, Jan-Bernd;
- Li, Chao;
- Chen, Shiuhwei;
- Zhu, Yi;
- Jiang, Nisi;
- Li, Guannan;
- Xu, Ziying;
- Wyler, Steven C.;
- Wang, May-Yun;
- Bai, Juli
Publication type:
Article
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency.
Published in:
Science Translational Medicine, 2023, v. 15, n. 723, p. 1, doi. 10.1126/scitranslmed.add4897
By:
- Altarejos, Judith Y.;
- Pangilinan, Jeffrey;
- Podgrabinska, Simona;
- Akinci, Baris;
- Foss-Freitas, Maria;
- Neidert, Adam H.;
- Ray, Yonaton;
- Zheng, Wenjun;
- Kim, Steven;
- Kamat, Vishal;
- Huang, Meilin;
- Min, Soo;
- Mastaitis, Jason;
- Dominguez-Gutierrez, Giselle;
- Kim, Jee-Hae;
- Stevis, Panayiotis;
- Huang, Tammy;
- Zambrowicz, Brian;
- Olson, William C.;
- Godin, Stephen
Publication type:
Article

Works matching IS 19466234 AND DT 2023 AND VI 15 AND IP 723

Translating models of obesity to tackle common obesity.

Seeking satiety: From signals to solutions.

Obesity and lifespan, a complex tango.

Evidence for the contribution of the gut microbiome to obesity and its reversal.

Metaflammation in obesity and its therapeutic targeting.

Hyperleptinemia contributes to antipsychotic drug–associated obesity and metabolic disorders.

Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency.